Live feed09:02:16·1895dSECFilingvia QuantisnowNeurocrine Biosciences, Inc. filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.NBIX· Neurocrine Biosciences Inc.Health CareOriginal source